Adma Biologics Inc. (ADMA)
NASDAQ · Healthcare
Adma Biologics Inc. Long Term Debt 2020–2025
Adma Biologics Inc. annual long term debt history from 2020 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Adma Biologics Inc. long term debt as of December 31, 2025: 76.0M, a 6.08% decrease year-over-year.
- Adma Biologics Inc. long term debt for 2025 were 76.0M, a 6.08% decrease from 2024.
- Adma Biologics Inc. long term debt for 2024 were 80.9M, a 42.37% decrease from 2023.
- Adma Biologics Inc. long term debt for 2023 were 140.4M, a 8.57% decrease from 2022.
- Adma Biologics Inc. long term debt for 2022 were 153.5M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Adma Biologics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $76 |
| 2024 | $81 |
| 2023 | $140 |
| 2022 | $154 |
| 2021 | $102 |
| 2020 | $97 |
Adma Biologics Inc. Long Term Debt — FAQ
Adma Biologics Inc. (ADMA) long term debt over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ADMA's long term debt history?
The chart and table above show Adma Biologics Inc.'s long term debt by year and by quarter, including the growth rate.